Not surprised at Dr. Donta's response. Raphael's comeback is pretty good, though.
For full disclosure, I was a patient of Dr. Donta and I wasn't impressed with his methodology and approach. Aside from expanding abx treatment for Lyme, he's been pretty much in line with IDSA on everything else. They still kicked him out of the 2006 Lyme IDSA panel for his views on abx treatment.
Beyond that, he seems to focus on Doxy and plaquenil as the only treatment for long term Lyme. I was underwhelmed in more ways than one, frankly.
Also quite interesting how quickly IDSA panel member Dr. Baker jumped on this study citing outdated studies to bash any findings. I could have predicted this.
One thing is right, though, the study could have used a larger sample and also collected other body fluids for comparison. Just my thoughts.